Compare ConocoPhillips (COP) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ConocoPhillips vs Quest Diagnostics Inc — how do they compare? ConocoPhillips trades at $125.33 (market cap $151.27B), while Quest Diagnostics Inc trades at $237.5 (market cap $26.21B). The key difference: ConocoPhillips is far larger — about 5.8× Quest Diagnostics Inc's market cap, and ConocoPhillips pays the higher dividend (2.67%). Which is the better fit depends on your goals.
| COP | DGX | |
|---|---|---|
Market Cap | $151.27B | $26.21B |
Sector | Energy | Health |
52-Week High | $133.80 | $238.50 |
52-Week Low | $85.66 | $173.49 |
Enterprise Value | $166.87B | $31.97B |
Dividend Yield | 2.67% | 1.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ConocoPhillips
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
